Conmed Osake

Conmed EBIT per osake

EBIT per osake yhtiöstä Conmed (CNMD) 17.8.2026 päivämäärällä on 3,29 USD. Edellisenä vuonna EBIT per osake oli 6,44 USD — muutos −48,85 % (matalampi).

EBIT per osake

3,29USD

YoY

−48,85%

Viimeksi päivitetty:

EBIT per osake yhtiöstä Conmed on 2026 3,29 USD. EBIT per osake yhtiöstä Conmed oli 2025 6,44 USD. Se laskee −48,85% matalampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Conmed Osakeanalyysi

Mitä Conmed tekee? Conmed Corporation is a leading medical technology company that offers a wide range of surgical instruments and devices for the fields of gastroenterology, endoscopy, orthopedics, gynecology, and electro surgery. The company was founded in 1970 and is headquartered in Utica, New York. The history of Conmed Corp began with the founding of Consolidated Medical Equipment, Inc. (CME) in 1970. The company initially started its business with the distribution of surgical instruments and devices for medical applications and quickly expanded in this field. In the 1980s, the company went public. In the 1990s, the company changed its name to Conmed Corporation and expanded its activities into the field of electro surgery, which has since become a major growth driver for the company. Today, Conmed Corp operates multiple manufacturing facilities worldwide and has sales offices in over 50 countries. The company is divided into four main business segments: gastroenterology, endoscopy, orthopedics, and electro surgery. The gastroenterology segment includes products for the diagnosis and treatment of gastrointestinal disorders, such as endoscopes, biopsy instruments, dilation balloons, trocars, and shears. In the endoscopy segment, Conmed Corp offers products for the diagnosis and treatment of digestive tract disorders, including endoscopes, biopsy instruments, dilation balloons, trocars, and shears. The orthopedics segment includes a wide range of surgical instruments and devices for the treatment of musculoskeletal disorders, including implants, bandages, bone plates, intramedullary nails, and others. Finally, the electro surgery segment is the fastest-growing segment of Conmed Corp and includes a wide range of devices for precision surgery, including electrocautery, electro surgery, endoscopy, and laparoscopy devices. Conmed Corp aims to develop innovative medical technologies that meet the needs of patients and healthcare professionals. The company places great emphasis on producing high-quality products that are reliable and safe. Conmed Corp is a successful company that continues to evolve and expand its product range to meet the rapidly evolving needs of the medical community. Conmed on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Conmed osakkeesta

Yhtiön Conmed EBIT per osake on 3,29 USD vuonna 2026.

EBIT per osake yhtiöstä Conmed muuttui arvosta 6,44 USD arvoon 3,29 USD, mikä edustaa −48,85 % muutosta. Arvo on matalampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EBIT per osake Conmed:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EBIT per osake mittaa operatiivisen voiton, joka on kohdistettu kullekin ulkona olevalle osakkeelle.

Access this data via the Eulerpool API

Tuloslaskelma — Conmed

Kaikki tunnusluvut — Conmed